KIRKLAND, QC, Dec. 12, 2018 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) ("Ortho RTi" or the "Corporation"), an emerging Orthopaedic and Sports Medicine technology company, announced that its recently completed study has been chosen by a peer reviewed panel as worthy of a podium presentation at the 2019 ICORS (International Combined meeting of Orthopaedic Research Societies) congress
DECEMBER 12, 2018 / BY FINK DENSFORD The U.S. Court of Appeals for the Federal Circuit this week affirmed Stryker‘s (NYSE:SYK) enhanced $248 million win in a surgical tool patent case against Zimmer Biomet (NYSE:ZBH). The Federal Circuit court affirmed the judgement in a per curiam ruling dated on Monday, according to recently released court documents. The damages in the case were previously enhanced due
December 12, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced plans to showcase its entire Orthobiologics franchise, including HYALOFAST, at the upcoming ICRS Focus Meeting in Milan, Italy at the Humanitas Research University. The ICRS is the
December 12, 2018 DALLAS--(BUSINESS WIRE)--DJO (“DJO” or the “Company”), a leading global provider of medical technologies designed to get and keep people moving, today announced its plans to relocate its global headquarters from San Diego, California to Dallas, Texas by early 2019. DJO’s Bracing and Supports business unit, which develops and markets DonJoy®, the market-leading
CAMARILLO, CALIF. (PRWEB) DECEMBER 11, 2018 A new clinical study published in the Journal of Arthroplasty comparing total knee replacement (TKR) surgery with and without use of the traditional thigh tourniquet demonstrated that female patients in the no-tourniquet group experienced significantly less post-operative pain and consumed fewer opioids as compared to female patients in the tourniquet
SALT LAKE CITY, Dec. 11, 2018 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has approved a Clinical Trial Notification (CTN) application for IDCT, an allogeneic injectable
December 11, 2018 MEMPHIS, Tenn.--(BUSINESS WIRE)--In2Bones Global, Inc. today announced the global launch of the unique, “see-through” PitStop®implant. Manufactured from a high-performance polymer called polyether ether ketone (PEEK), the PitStop® Implant is used to help facilitate the surgical correction of progressive flat foot deformity in both pediatric and adult populations. Flexible flatfoot is one of the most common deformities
By Fred Donovan December 10, 2018 - Global institutional investors are forecast to increase their investment in healthcare infrastructure by $200 billion over the next five years. For its report, the Octopus Group surveyed more than 100 global institutional investors with a total of $6.8 trillion in assets under management. The institutions said they currently allocated 6.1 percent of
December 8, 2018 / Peter Nichol It is estimated that 30% of healthcare costs are lost to waste in the system. These costs get passed on to the insurer and ultimately the patients. With healthcare bills being the leading cause of personal bankruptcies in the country (60%) that 30% is the difference between solvency and destitution
MISGAV, Israel, Dec. 10, 2018 /PRNewswire/ -- ZygoFix Ltd. ("ZygoFix"), a portfolio company of The Trendlines Group Ltd.("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced the successful start of a first In human clinical study for its zLOCK spinal facet joint fixation system. The clinical study comprised several procedures to date and a 6-month follow-up of the first case. The first case, a
